In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exploring Price Transparency Actions In Europe

Drug Pricing, An Issue That Will Not Go Away

Executive Summary

Drug pricing is an issue that is not going to go away. For many the problem relates to prices being too high, for others it is simply that the real prices paid for products is not clear, nor is it transparent how those prices come about. 

You may also be interested in...



Where Now For Italy’s Drug Price Transparency Crusade?

The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.

The Tensions In Pursuing Drug Price Transparency In Belgium

In Belgium, there are increasing tensions between drug price transparency and getting the best deal for the Belgian government.

A Look At The New Leadership Team At NICE

The new appointments to the top jobs at NICE may bring continuity at a challenging time for the institute, but perhaps not the real change that some in the industry say is needed. 

Topics

UsernamePublicRestriction

Register

PS142217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel